Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?-Reference-Cited by-同舟云学术

Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?

Published:2022-10-18 Issue:2 Volume:44 Page:659-665
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Paybast Sepideh,Habibi Mohammad Amin,Naser Moghadasi Abdorreza^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-022-06447-4.pdf

Reference21 articles.

1. Karim SSA, Karim QA (2021) Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. The Lancet 398(10317):2126–2128

2. Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN et al (2021) Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29(1):44-57.e9

3. Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM et al (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 19(7):409–424

4. Reyes S, Cunningham AL, Kalincik T, Havrdová EK, Isobe N, Pakpoor J et al (2021) Update on the management of multiple sclerosis during the COVID-19 pandemic and post-pandemic: an international consensus statement. J Neuroimmunol 357:577627

5. Reder AT, Centonze D, Naylor ML, Nagpal A, Rajbhandari R, Altincatal A et al (2021) COVID-19 in patients with multiple sclerosis: associations with disease-modifying therapies. CNS Drugs 35(3):317–330

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of T follicular helper cells in autoimmune rheumatic Diseases: A systematic review on immunopathogenesis and response to treatment;Human Immunology;2024-09

2. Low-dose rituximab regimen does not increase severe COVID-19 risk in patients with neuroimmune diseases during the pandemic: a cross-sectional study;2024-07-29

3. Prognostic performance of magnetic resonance spectrometry in patients with diffuse axonal injury: A prospective cohort study;Interdisciplinary Neurosurgery;2024-06

4. The Role of Electroencephalography in the Prediction of Relapse of Febrile Convulsion in Patients Aged Between 6 to 60 Months: A Prospective Cohort Study;Journal of Pediatric Neurology;2024-05-30

5. Prediction of the treatment response and local failure of patients with brain metastasis treated with stereotactic radiosurgery using machine learning: A systematic review and meta-analysis;Neurosurgical Review;2024-04-30